Oxford vaccine clinical trial results could be available December: Scientists

Emmanuel Akosile | ConsumerConnect

Experts at Britain’s Oxford University, who are partnering with drugmaker AstraZeneca on a vaccine candidate, have disclosed that they believe clinical trial results could be available before the end of this year.

Researchers are preparing for the final steps in the process, which involve having government regulators carefully review the data and decide whether the vaccine should be approved and distributed to the public, Reuters report said.

The vaccine candidate produced by Oxford and AstraZeneca is expected to be one of the first from major pharmaceutical companies to complete the testing process and be submitted for regulatory approval.

Pfizer and BioNTech’s candidate is also reportedly near the end of the process, stated the report.

Kindly Share This Story